Skip to main content
Fig. 1 | Cancer Cell International

Fig. 1

From: Targeted drug delivery using nanobodies to deliver effective molecules to breast cancer cells: the most attractive application of nanobodies

Fig. 1

Nanobody, or VHH, is the variable segment of camel heavy chain antibodies, which consists of 4 conserved sequence segments (FR1/2/3/4) and 3 highly variable loops (complementarity-determining regions, CDR1/2/3) located at the tip of Nb. The CDR part of these nanobodies is wider than conventional antibodies and plays an important role in antigen binding

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us